Wealthfront Advisers’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.99M Buy
42,240
+27,046
+178% +$3.34M 0.01% 421
2025
Q4
$1.91M Sell
15,194
-22,026
-59% -$2.87M ﹤0.01% 601
2025
Q3
$5.45M Buy
37,220
+13,097
+54% +$1.98M 0.01% 375
2025
Q2
$3.76M Sell
24,123
-90
-0.4% -$14.3K 0.01% 433
2025
Q1
$3.99M Buy
24,213
+4,790
+25% +$797K 0.01% 397
2024
Q4
$3.16M Sell
19,423
-954
-5% -$171K 0.01% 422
2024
Q3
$3.98M Buy
20,377
+935
+5% +$172K 0.01% 358
2024
Q2
$3.37M Sell
19,442
-3,031
-13% -$504K 0.01% 360
2024
Q1
$3.8M Sell
22,473
-462
-2% -$86.5K 0.01% 335
2023
Q4
$4.53M Sell
22,935
-5,150
-18% -$912K 0.02% 265
2023
Q3
$4.89M Buy
28,085
+1,904
+7% +$346K 0.02% 215
2023
Q2
$4.51M Sell
26,181
-3,413
-12% -$590K 0.02% 237
2023
Q1
$4.93M Buy
29,594
+1,775
+6% +$291K 0.02% 207
2022
Q4
$4.08M Buy
27,819
+4,130
+17% +$611K 0.02% 238
2022
Q3
$3.51M Sell
23,689
-18,944
-44% -$3.17M 0.02% 245
2022
Q2
$7.33M Buy
42,633
+8,699
+26% +$1.5M 0.04% 131
2022
Q1
$6.4M Sell
33,934
-4,331
-11% -$856K 0.03% 168
2021
Q4
$9.34M Buy
38,265
+3,482
+10% +$763K 0.04% 107
2021
Q3
$6.75M Buy
34,783
+5,490
+19% +$1.11M 0.03% 125
2021
Q2
$5.46M Buy
29,293
+6,255
+27% +$1.09M 0.03% 128
2021
Q1
$3.63M Buy
23,038
+4,354
+23% +$690K 0.02% 157
2020
Q4
$3.09M Sell
18,684
-244
-1% -$39.7K 0.02% 146
2020
Q3
$3.13M Sell
18,928
-70
-0.4% -$10.8K 0.02% 120
2020
Q2
$2.6M Sell
18,998
-3,145
-14% -$411K 0.02% 125
2020
Q1
$2.61M Buy
22,143
+6,683
+43% +$880K 0.02% 110
2019
Q4
$2.05M Sell
15,460
-1,120
-7% -$139K 0.02% 174
2019
Q3
$2.07M Buy
16,580
+2,372
+17% +$286K 0.02% 159
2019
Q2
$1.61M Buy
14,208
+431
+3% +$45.1K 0.01% 183
2019
Q1
$1.39M Sell
13,777
-7
-0.1% -$636 0.01% 201
2018
Q4
$1.18M Buy
+13,784
New +$1.24M 0.01% 208

Other funds holding ZTS

Wealthfront Advisers's ZTS Position: Q1 2026 in Review

Wealthfront Advisers increased its Zoetis (ZTS) stake by 178% in Q1 2026, buying an estimated $3.34M and bringing the position to 42,240 shares worth $4.99M. The position accounts for 0.01% of the portfolio, ranked #421.

Wealthfront Advisers first reported a position in ZTS in Q4 2018 and has held it in 30 quarters since. The position peaked at $9.34M in Q4 2021. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Wealthfront Advisers held 42,240 shares of Zoetis worth $4.99M as of Q1 2026.
  • Wealthfront Advisers bought 27,046 Zoetis shares in Q1 2026, an estimated $3.34M.
  • Zoetis made up 0.01% of Wealthfront Advisers's portfolio in Q1 2026, its #421 holding.
  • Wealthfront Advisers first reported a position in Zoetis in Q4 2018 and has held it in 30 quarters since.
  • Wealthfront Advisers's Zoetis position peaked at $9.34M in Q4 2021.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.